TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04329858 — Surrogate Endpoint (SUR): Bacterial count
Study NCT06061874 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06413563 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00000949 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06133205 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05528354 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06607796 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT06531148 — Surrogate Endpoint (SUR): Bacterial count
Study NCT06612593 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT06612593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06612593 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT06612593 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT04757090 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05075603 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06078163 — Safety Biomarker (SAF): L-acetylcarnitine
Study NCT05348343 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06529549 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06529549 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT06441578 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT06017687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03176498 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04750330 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT04640103 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05871736 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04643327 — Predictive Biomarker (PRD): CA3 mRNA
Genes: CA3
Study NCT06113744 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05775874 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT05775874 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT06471465 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04898907 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT05946915 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study NCT04623190 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05928780 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT06553339 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT05679687 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06090149 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03052569 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04933825 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01134692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01134692 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05220514 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06059794 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05160649 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04464967 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04464967 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04510584 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06201741 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00002307 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04959916 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06330948 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study NCT05683418 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05367310 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT05764044 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT05183334 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT06049862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06084234 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05456074 — Predictive Biomarker (PRD): TFE3 mRNA
Genes: TFE3; BHLHE33
Study NCT05456074 — Predictive Biomarker (PRD): TFEB mRNA
Genes: TFEB; BHLHE35
Study NCT06357338 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT00041613 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04386252 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04888910 — Predictive Biomarker (PRD): IL5RA mRNA
Genes: IL5RA; IL5R
Study NCT06336863 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06554392 — Predictive Biomarker (PRD): GPX4 mRNA
Genes: GPX4
Study NCT05912322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05003648 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT04765124 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05718778 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05886543 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06175650 — Predictive Biomarker (PRD): CPB1 mRNA
Genes: CPB1; CPB; PCPB
Study NCT06352866 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05252403 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06391073 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05928039 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06103708 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05764356 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06152523 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06152523 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06152523 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT06152523 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study NCT06152523 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT05388994 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05198856 — Predictive Biomarker (PRD): IKZF1 mRNA
Genes: IKZF1; IK1; IKAROS; LYF1; ZNFN1A1
Study NCT05198856 — Predictive Biomarker (PRD): IKZF3 mRNA
Genes: IKZF3; ZNFN1A3
Study NCT04742946 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05633433 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04521153 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06108427 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06379373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06379373 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06379373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06379373 — Monitoring Biomarker (MOI): Complement C4
Study NCT04700709 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT04851834 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT04851834 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06498154 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06498154 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05497453 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT05460871 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05251090 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT06095583 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT06536504 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT06688435 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04976439 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04976439 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04976439 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04976439 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04976439 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study NCT06416072 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06416072 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05118386 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06485258 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05543733 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT05564429 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05309421 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05793281 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT05389943 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05065645 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05065645 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06145139 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06100471 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04758195 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT05575271 — Predictive Biomarker (PRD): NE
Study NCT00228839 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06083662 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06083662 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06083662 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT05960526 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04218903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06367946 — Predictive Biomarker (PRD): KLK8 mRNA
Genes: KLK8; NRPN; PRSS19; TADG14; UNQ283/PRO322
Study NCT05139238 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05270317 — Predictive Biomarker (PRD): BMP2 mRNA
Genes: BMP2; BMP2A
Study NCT05270317 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study NCT05270317 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT05270317 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT04814667 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT04814667 — Predictive Biomarker (PRD): NTRK
Study NCT04820803 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06254248 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT06173388 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04334070 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT05782491 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00004736 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05640713 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05987826 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05987826 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05854485 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05493176 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06512922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06015126 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06254430 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05749133 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06074783 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06074783 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05699746 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05301465 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05301465 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT05301465 — Predictive Biomarker (PRD): VEGF
Genes: VEGFA; VEGF-A; VPF
Study NCT05301465 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05345327 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05760209 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT05769608 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05435014 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05435014 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT05297617 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05297617 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05297617 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04752839 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04980768 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06469450 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06331598 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT06331598 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05006911 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05513703 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00000804 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06215066 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05143632 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05649514 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05138601 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05801276 — Predictive Biomarker (PRD): CDO1 mRNA
Genes: CDO1
Study NCT05801276 — Predictive Biomarker (PRD): HOXA9 mRNA
Genes: HOXA9; HOX1G
Study NCT05801276 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05426707 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05575739 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06199947 — Predictive Biomarker (PRD): OSM mRNA
Genes: OSM
Study NCT04854759 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05177003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05667155 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05667155 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT00002250 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06336317 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06336317 — Safety Biomarker (SAF): Interleukin 1
Study NCT06336317 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06336317 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06095375 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04927039 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05865639 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06491953 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06611098 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05623137 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study NCT01013714 — Predictive Biomarker (PRD): CSAD mRNA
Genes: CSAD; CSD
Study NCT05295303 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06121518 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04246203 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05155592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06520527 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05858710 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT06110793 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06666439 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05862051 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study NCT06746961 — Predictive Biomarker (PRD): CLTA mRNA
Genes: CLTA
Study NCT06261502 — Predictive Biomarker (PRD): FMR1 mRNA
Genes: FMR1
Study NCT05039177 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06480305 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05069532 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05645289 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05402852 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05903690 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06317064 — Predictive Biomarker (PRD): TACR1 mRNA
Genes: TACR1; NK1R; TAC1R
Study NCT06476626 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study NCT06309823 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT06309823 — Predictive Biomarker (PRD): NLRC4 mRNA
Genes: NLRC4; CARD12; CLAN; CLAN1; IPAF; UNQ6189/PRO20215
Study NCT06144671 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05906147 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05334823 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01215890 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04258332 — Predictive Biomarker (PRD): SSBP1 mRNA
Genes: SSBP1; SSBP
Study NCT04258332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04258332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04258332 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05334147 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05642273 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05642273 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05642273 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05597800 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05275751 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT05275751 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT05275751 — Predictive Biomarker (PRD): TRPM3 mRNA
Genes: TRPM3; KIAA1616; LTRPC3
Study NCT05028309 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05649475 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05126056 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT05126056 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06492785 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04676711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04848636 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05449171 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06381258 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05391360 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06274164 — Predictive Biomarker (PRD): RAI1 mRNA
Genes: RAI1; KIAA1820
Study NCT05938725 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05939817 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05939817 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05197686 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05740761 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT05630664 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05745896 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06056869 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT00002333 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04956263 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study NCT04956263 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04453397 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06336031 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05115500 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04806412 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04806412 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04806412 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04806412 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05682833 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04710875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04770506 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05719090 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06529354 — Surrogate Endpoint (SUR): Blood pressure